1. Search Result
Search Result
Results for "

selective chemical probe

" in MedChemExpress (MCE) Product Catalog:

171

Inhibitors & Agonists

6

Screening Libraries

1

Fluorescent Dyes

1

Click Chemistry

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-107455
    A-485
    Maximum Cited Publications
    99 Publications Verification

    Epigenetic Reader Domain Histone Acetyltransferase Cancer
    A-485, a chemical probe, is a potent and selective catalytic inhibitor of p300/CBP with IC50s of 9.8 nM and 2.6 nM for p300 and CBP histone acetyltransferase (HAT), respectively .
    A-485
  • HY-100411
    MLi-2
    10+ Cited Publications

    LRRK2 Neurological Disease
    MLi-2, a chemical probe, is an orally active and highly selective LRRK2 inhibitor with an IC50 of 0.76 nM. MLi-2 has the potential for Parkinson’s disease .
    MLi-2
  • HY-102080
    SAFit2
    5+ Cited Publications

    FKBP Cancer
    SAFit2, a chemical probe, is a highly potent, highly selective FK506-binding protein 51 (FKBP51) inhibitor with a Ki of 6 nM and also enhances AKT2-AS160 binding .
    SAFit2
  • HY-13500
    GSK343
    30+ Cited Publications

    Histone Methyltransferase Autophagy Cancer
    GSK343, a chemical probe, is a highly potent and selective EZH2 inhibitor with an IC50 of 4 nM.
    GSK343
  • HY-18966
    PF-04418948
    10+ Cited Publications

    Prostaglandin Receptor Endocrinology Cancer
    PF-04418948, a chemical probe, is an orally active, potent and selective prostaglandin EP2 receptor antagonist with an IC50 of 16 nM .
    PF-04418948
  • HY-119254
    BAY-850
    5 Publications Verification

    Epigenetic Reader Domain Metabolic Disease
    BAY-850, a chemical probe, is a potent and isoform selective ATPase family AAA domain-containing protein 2 (ATAD2) inhibitor, with an IC50 of 166 nM .
    BAY-850
  • HY-101787
    TP-024
    2 Publications Verification

    FTBMT

    GPR52 Neurological Disease
    TP-024 (FTBMT), a chemical probe, is a selective GPR52 agonist with an EC50 of 75 nM . TP-024 has antipsychotic and procognitive properties .
    TP-024
  • HY-19615
    MS023
    20+ Cited Publications

    Histone Methyltransferase Cancer
    MS023, a chemical probe, is a potent, selective, and cell-active inhibitor of human type I protein arginine methyltransferases (PRMTs) inhibitor, with IC50s of 30, 119, 83, 4 and 5 nM for PRMT1, PRMT3, PRMT4, PRMT6, and PRMT8, respectively .
    MS023
  • HY-15646
    UNC1999
    10+ Cited Publications

    Histone Methyltransferase Autophagy Cancer
    UNC1999, a chemical probe, is a SAM-competitive, potent and selective inhibitor of EZH2/1 with IC50s of <10 nM and 45 nM, repectively.
    UNC1999
  • HY-19715
    SGC707
    10+ Cited Publications

    Histone Methyltransferase Metabolic Disease
    SGC707, a chemical probe, is a potent, selective, and non-competitive PRMT3 (protein arginine methyltransferase 3) inhibitor (IC50=31 nM, Kd=53 nM).
    SGC707
  • HY-100235
    GSK591
    10+ Cited Publications

    EPZ015866; GSK3203591

    Histone Methyltransferase Cancer
    GSK591 (EPZ015866), a chemical probe, is a potent and selective inhibitor of protein methyltransferase 5 (PRMT5) with an IC50 of 4 nM .
    GSK591
  • HY-112445
    SGC3027
    5+ Cited Publications

    Histone Methyltransferase Cancer
    SGC3027 is a histone methyltransferase inhibitor . SGC3027 is the first potent, selective and cell active chemical probe for PRMT7 .
    SGC3027
  • HY-100018
    BAY1125976
    3 Publications Verification

    Akt Cancer
    BAY1125976, a chemical probe, is a selective allosteric Akt1/Akt2 inhibitor; inhibits Akt1 and Akt2 activity with IC50 values of 5.2 nM and 18 nM at 10 μM ATP, respectively.
    BAY1125976
  • HY-19725
    A-1155463
    20+ Cited Publications

    Bcl-2 Family Cancer
    A-1155463, a chemical probe, is a highly potent and selective BCL-XL inhibitor with an EC50 of 70 nM in Molt-4 cell. A-1155463 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
    A-1155463
  • HY-100519
    NVS-PAK1-1
    5 Publications Verification

    PAK Cancer
    NVS-PAK1-1, a chemical probe, is a potent and selective allosteric PAK1 inhibitor with an IC50 of 5 nM .
    NVS-PAK1-1
  • HY-13980
    UNC0642
    20+ Cited Publications

    Histone Methyltransferase Cancer
    UNC0642, a chemical probe, is a potent and selective lysine methyltransferases G9a and GLP inhibitor, with an IC50 of <2.5 nM for G9a.
    UNC0642
  • HY-102058
    WM-1119
    10+ Cited Publications

    Histone Acetyltransferase Cancer
    WM-1119, a chemical probe, is a highly potent and selective KAT6A inhibitor, with an IC50 of 0.25 μM for KAT6A in lymphoma cells, the binding KD values of WM-1119 with KAT6A, KAT5 and KAT7 are 2 nM, 2.2 μM, 0.5 μM , respectively .
    WM-1119
  • HY-12409
    PFI-3
    5 Publications Verification

    Epigenetic Reader Domain Cancer
    PFI-3, a chemical probe, is a selective, potent and cell-permeable SMARCA2/4 bromodomain inhibitor with a Kd of 89 nM.
    PFI-3
  • HY-122186
    SGC-GAK-1
    2 Publications Verification

    Cyclin G-associated Kinase (GAK) Cancer
    SGC-GAK-1 is a potent, selective cyclin G-associated kinase (GAK) inhibitor with a Ki of 3.1 nM. SGC-GAK-1 is a chemical probe for GAK .
    SGC-GAK-1
  • HY-107777
    LLY-283
    5+ Cited Publications

    Histone Methyltransferase Cancer
    LLY-283, a chemical probe, is a potent, selective and oral protein arginine methyltransferase 5 (PRMT5) inhibitor, with an IC50 of 22 nM and a Kd of 6 nM for PRMT5:MEP50 complex, and shows antitumor activity .
    LLY-283
  • HY-107725
    BIBO3304
    4 Publications Verification

    Neuropeptide Y Receptor Metabolic Disease
    BIBO3304, a chemical probe, is a potent, orally active, and selective neuropeptide Y (NPY) Y1 receptor antagonist, with subnanomolar affinity for both the human and the rat Y1 receptor (IC50=0.38 and 0.72 nM, respectively) .
    BIBO3304
  • HY-15300
    Skepinone-L
    2 Publications Verification

    CBS3830

    p38 MAPK Autophagy Inflammation/Immunology
    Skepinone-L (CBS3830), a chemical probe, is a selective p38 mitogen-activated protein kinase inhibitor.
    Skepinone-L
  • HY-19546
    BAY-598
    5+ Cited Publications

    Histone Methyltransferase Cancer
    BAY-598, a chemical probe, is selective small molecule inhibitor of SMYD2 with an IC50 of 27 nM .
    BAY-598
  • HY-153045
    BAY-805
    3 Publications Verification

    Deubiquitinase Cancer
    BAY-805, a chemical probe, is a selective inhibitor of ubiquitin-specific protease USP21. BAY-805 has high selectivity for deubiquitinating enzyme (DUB) targets, kinases, proteases and other common target enzymes .
    BAY-805
  • HY-14376
    Redafamdastat
    5+ Cited Publications

    PF-04457845

    FAAH Autophagy Neurological Disease
    Redafamdastat (PF-04457845), a chemical probe, is a highly efficacious and selective FAAH inhibitor with IC50 values is 7.2±0.63 nM and 7.4±0.62 nM for hFAAH and rFAAH, respectively.
    Redafamdastat
  • HY-12681
    CCT251545
    3 Publications Verification

    Wnt Cancer
    CCT251545 is an orally bioavailable and potent inhibitor of WNT signaling with an IC50 of 5 nM in 7dF3 cells . CCT251545 is a selective chemical probe for exploring the role of CDK8 and CDK19 in human disease .
    CCT251545
  • HY-15658
    GSK2801
    3 Publications Verification

    Epigenetic Reader Domain Apoptosis Cancer
    GSK2801, a chemical probe, is a potent, selective, orally active and cell active acetyl-lysine competitive BAZ2A and BAZ2B bromodomains inhibitor with Kd values of 136 nM and 257 nM, respectively. GSK2801 shows >50-fold selectivity for BAZ2A/B over BRD4 .
    GSK2801
  • HY-133117
    BAY-985
    4 Publications Verification

    IKK Cancer
    BAY-985, a chemical probe, is a highly potent, orally active and selective ATP-competitive dual inhibitor of TBK1 and IKKε with IC50s of 2/30 and 2 nM for TBK1 (low/high ATP) and IKKε, respectively. Antitumor efficacy .
    BAY-985
  • HY-130248
    BAY-899
    1 Publications Verification

    GnRH Receptor Endocrinology
    BAY-899, a chemical probe, is an orally active and selective luteinizing hormone receptor (LH-R) antagonist with IC50s of 185 nM and 46nM for hLH (human LH) and rLH (rat LH), respectively. BAY-899 can reduce sex hormone levels .
    BAY-899
  • HY-19313
    LLY-507
    10+ Cited Publications

    Histone Methyltransferase Cancer
    LLY-507 is a potent and selective inhibitor of protein-lysine methyltransferase SMYD2. LLY-507 potently inhibits the ability of SMYD2 to methylate p53 peptide with an IC50 <15 nM. LLY-507 serves as a valuable chemical probe to aid in the dissection of SMYD2 function in cancer and other biological processes .
    LLY-507
  • HY-148814
    BI-3231
    2 Publications Verification

    17β-HSD Metabolic Disease
    BI 3231, a chemical probe, is a potent and selective hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) inhibitor, with IC50s of 1 and 13 nM for hHSD17B13 and mHSD17B13, respectively. BI 3231 has the potential for the research of nonalcoholic steatohepatitis (NASH) and other liver diseases .
    BI-3231
  • HY-108886
    JWG-071
    5 Publications Verification

    ERK Cancer
    JWG-071 is the kinase-selective chemical probe for ERK5. JWG-071 inhibits ERK5 and LRRK2 with IC50 values of 88nM and 109 nM, respectively .
    JWG-071
  • HY-151813

    Fluorescent Dye Cancer
    NNMT-IN-4 (compound 38) is a selective, uncompetitive and membrane permeability nicotinamide N-methyltransferase (NNMT) inhibitor with IC50 values of 42 and 38 nM in vitro biochemical and cell-based assays, respectively. NNMT-IN-4 shows favorable PK/PD and safety profiles as well as excellent oral bioavailability and pharmaceutical properties. NNMT-IN-4 can be used as a vivo chemical probe of NNMT .
    NNMT-IN-4
  • HY-100756
    BAY-826
    1 Publications Verification

    Discoidin Domain Receptor Tie Cancer
    BAY-826, a chemical probe, is a selective and potent TIE-2 inhibitor with a Kd of 1.6 nM, respectively.
    BAY-826
  • HY-16586
    PFI-1
    3 Publications Verification

    Epigenetic Reader Domain Autophagy Apoptosis Cancer
    PFI-1, a chemical probe, is a selective BET (bromodomain-containing protein) inhibitor for BRD4 with IC50 of 0.22 μM in a cell-free assay.
    PFI-1
  • HY-115506

    TRP Channel Neurological Disease
    PF-05105679, a chemical probe, is an orally active and selective TRPM8 antagonist with an IC50 of 103 nM. PF-05105679 has the potential for cold-related pain .
    PF-05105679
  • HY-100220
    GSK6853
    2 Publications Verification

    Epigenetic Reader Domain Cancer
    GSK6853, a chemical probe, is a potent and selective inhibitor of the BRPF1 bromodomain. GSK6853 shows excellent BRPF1 potency (pKd = 9.5) and greater than 1600-fold selectivity over all other bromodomains .
    GSK6853
  • HY-15649
    UNC1215
    4 Publications Verification

    Histone Methyltransferase Apoptosis Cancer
    UNC1215, a chemical probe, is a potent and selective inhibitor for the methyllysine (Kme) reading domain function of L3MBTL3 with a Kd value of 120 nM and an IC50 of 40 nM. UNC1215 has the potential to treat malignant brain tumor.
    UNC1215
  • HY-112803

    DNA/RNA Synthesis Cancer
    GNE-371 is a potent and selective chemical probe for the second bromodomains of human transcription-initiation-factor TFIID subunit 1 and transcription-initiation-factor TFIID subunit 1-like, with an IC50 of 10 nM for TAF1(2).
    GNE-371
  • HY-100518
    T-26c
    3 Publications Verification

    MMP Inflammation/Immunology
    T-26c, a chemical probe, is highly potent and selective matrix metalloproteinase-13 (MMP-13) inhibitor with an IC50 of 6.75 pM and more than 2600-fold selectivity over the other related metalloenzymes .
    T-26c
  • HY-101125
    L-Moses
    2 Publications Verification

    L-45

    Epigenetic Reader Domain Cancer
    L-Moses (L-45), a chemical probe, is the first potent, selective, and cell-active p300/CBP-associated factor (PCAF) bromodomain (Brd) inhibitor with a Kd of 126 nM .
    L-Moses
  • HY-124029

    MMP13-IN-3

    MMP Inflammation/Immunology
    BI-4394 (MMP13-IN-3), a chemical probe, is a potent, selective, and orally active MMP-13 inhibitor (IC50=1 nM ) for the potential treatment of osteoarthritis . BI-4394 is >1000 selective over other MMPs .
    BI-4394
  • HY-111457A
    BAY-678
    1 Publications Verification

    Elastase Inflammation/Immunology
    BAY-678 is an orally bioavailable, highly potent, selective and cell-permeable inhibitor of human neutrophil elastase (HNE), with an IC50 of 20 nM. BAY-678 is also nominated as a chemical probe to the public via the Structural Genomics Consortium (SGC).
    BAY-678
  • HY-137892

    Epigenetic Reader Domain Inflammation/Immunology
    GSK620, a chemical probe, is a potent and orally active pan-BD2 inhibitor with excellent broad selectivity, developability and in vivo oral pharmacokinetics. GSK620 is highly selective for the BET-BD2 family of proteins, with >200-fold selectivity over all other bromodomains. GSK620 shows an anti-inflammatory phenotype in human whole blood .
    GSK620
  • HY-100352
    BI-9564
    2 Publications Verification

    Epigenetic Reader Domain Cancer
    BI-9564, a chemical probe, is a potent, selective and cell-permeable BRD9/BRD7 bromodomains inhibitor, with IC50s of 75 nM and 3.4 μM and Kds of 14 nM and 239 nM, respectively. BI-9564 has an IC50 of > 100 μM for BET family .
    BI-9564
  • HY-16100
    BI 99179
    3 Publications Verification

    Fatty Acid Synthase (FASN) Metabolic Disease Cancer
    BI 99179, a chemical probe, is a potent and selective type I fatty acid synthase (FAS) inhibitor with an IC50 of 79 nM. BI 99179 is a tool compound suitable for the in vivo validation of FAS as a target for lipid metabolism related diseases. BI 99179 exhibits significant exposure (both peripheral and central) upon oral administration in rats .
    BI 99179
  • HY-139868

    PI5P4K Cancer
    BAY-091, a chemical probe, is a potent and highly selective inhibitor of the kinase PIP4K2A.
    BAY-091
  • HY-112082
    BAY885
    1 Publications Verification

    ERK Cancer
    BAY885, a chemical probe, is a highly potent and selective ERK5 inhibitor with an IC50 of 35 nM. BAY885 shows weak inhibition on others kinases .
    BAY885
  • HY-112080

    Histone Methyltransferase Cancer
    BAY-6035, a chemical probe, is a potent, selective and substrate-competitive inhibitor of SMYD3. BAY-6035 inhibits methylation of MEKK2 peptide with an IC50 of 88 nM .
    BAY-6035
  • HY-145707

    Mitochondrial Metabolism Cancer
    BAY-179, a chemical probe, is a potent, selective, and species cross-reactive complex I inhibitor. BAY-179 shows IC50 values of 79 nM, 38 nM, 27 nM, and 47 nM for human, mouse, rat, and dog complex I, respectively .
    BAY-179

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: